vs
Side-by-side financial comparison of INSTEEL INDUSTRIES INC (IIIN) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($311.4M vs $159.9M, roughly 1.9× INSTEEL INDUSTRIES INC). Bio-Techne runs the higher net margin — 16.4% vs 4.7%, a 11.6% gap on every dollar of revenue. On growth, INSTEEL INDUSTRIES INC posted the faster year-over-year revenue change (23.3% vs -1.5%). Over the past eight quarters, INSTEEL INDUSTRIES INC's revenue compounded faster (12.0% CAGR vs 1.3%).
Insteel Industries Inc is a leading U.S. manufacturer of steel reinforcing products including welded wire reinforcement and steel fibers. It primarily serves non-residential construction, infrastructure, and precast concrete segments across North America, delivering high-performance reinforcement solutions for various construction projects.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
IIIN vs TECH — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $159.9M | $311.4M |
| Net Profit | $7.6M | $51.0M |
| Gross Margin | 11.3% | 66.9% |
| Operating Margin | 6.0% | 24.2% |
| Net Margin | 4.7% | 16.4% |
| Revenue YoY | 23.3% | -1.5% |
| Net Profit YoY | 602.4% | 126.0% |
| EPS (diluted) | $0.39 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $311.4M | ||
| Q4 25 | $159.9M | $295.9M | ||
| Q3 25 | $177.4M | — | ||
| Q2 25 | $179.9M | $317.0M | ||
| Q1 25 | $160.7M | $316.2M | ||
| Q4 24 | $129.7M | $297.0M | ||
| Q3 24 | $134.3M | $289.5M | ||
| Q2 24 | $145.8M | $306.1M |
| Q1 26 | — | $51.0M | ||
| Q4 25 | $7.6M | $38.0M | ||
| Q3 25 | $14.6M | — | ||
| Q2 25 | $15.2M | $-17.7M | ||
| Q1 25 | $10.2M | $22.6M | ||
| Q4 24 | $1.1M | $34.9M | ||
| Q3 24 | $4.7M | $33.6M | ||
| Q2 24 | $6.6M | $40.6M |
| Q1 26 | — | 66.9% | ||
| Q4 25 | 11.3% | 64.6% | ||
| Q3 25 | 16.1% | — | ||
| Q2 25 | 17.1% | 62.7% | ||
| Q1 25 | 15.3% | 67.9% | ||
| Q4 24 | 7.3% | 65.3% | ||
| Q3 24 | 9.1% | 63.2% | ||
| Q2 24 | 10.6% | 66.4% |
| Q1 26 | — | 24.2% | ||
| Q4 25 | 6.0% | 18.4% | ||
| Q3 25 | 10.8% | — | ||
| Q2 25 | 11.0% | -7.5% | ||
| Q1 25 | 8.3% | 12.2% | ||
| Q4 24 | 1.1% | 16.0% | ||
| Q3 24 | 4.5% | 13.8% | ||
| Q2 24 | 6.0% | 15.0% |
| Q1 26 | — | 16.4% | ||
| Q4 25 | 4.7% | 12.8% | ||
| Q3 25 | 8.2% | — | ||
| Q2 25 | 8.4% | -5.6% | ||
| Q1 25 | 6.4% | 7.1% | ||
| Q4 24 | 0.8% | 11.7% | ||
| Q3 24 | 3.5% | 11.6% | ||
| Q2 24 | 4.5% | 13.3% |
| Q1 26 | — | $0.32 | ||
| Q4 25 | $0.39 | $0.24 | ||
| Q3 25 | $0.74 | — | ||
| Q2 25 | $0.78 | $-0.11 | ||
| Q1 25 | $0.52 | $0.14 | ||
| Q4 24 | $0.06 | $0.22 | ||
| Q3 24 | $0.24 | $0.21 | ||
| Q2 24 | $0.34 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.6M | $209.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $358.8M | $2.1B |
| Total Assets | $456.1M | $2.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $209.8M | ||
| Q4 25 | $15.6M | $172.9M | ||
| Q3 25 | $38.6M | — | ||
| Q2 25 | $53.7M | $162.2M | ||
| Q1 25 | $28.4M | $140.7M | ||
| Q4 24 | $36.0M | $177.5M | ||
| Q3 24 | $111.5M | $187.5M | ||
| Q2 24 | $97.7M | $152.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M |
| Q1 26 | — | $2.1B | ||
| Q4 25 | $358.8M | $2.0B | ||
| Q3 25 | $371.5M | — | ||
| Q2 25 | $356.2M | $1.9B | ||
| Q1 25 | $341.4M | $2.0B | ||
| Q4 24 | $331.6M | $2.1B | ||
| Q3 24 | $350.9M | $2.1B | ||
| Q2 24 | $346.0M | $2.1B |
| Q1 26 | — | $2.6B | ||
| Q4 25 | $456.1M | $2.5B | ||
| Q3 25 | $462.6M | — | ||
| Q2 25 | $471.9M | $2.6B | ||
| Q1 25 | $421.9M | $2.6B | ||
| Q4 24 | $404.7M | $2.7B | ||
| Q3 24 | $422.6M | $2.7B | ||
| Q2 24 | $414.6M | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-701.0K | — |
| Free Cash FlowOCF − Capex | $-2.2M | — |
| FCF MarginFCF / Revenue | -1.4% | — |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | -0.09× | — |
| TTM Free Cash FlowTrailing 4 quarters | $439.0K | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-701.0K | — | ||
| Q3 25 | $-17.0M | — | ||
| Q2 25 | $28.5M | $98.2M | ||
| Q1 25 | $-3.3M | $41.1M | ||
| Q4 24 | $19.0M | $84.3M | ||
| Q3 24 | $16.2M | $63.9M | ||
| Q2 24 | $18.8M | $75.5M |
| Q1 26 | — | — | ||
| Q4 25 | $-2.2M | — | ||
| Q3 25 | $-18.7M | — | ||
| Q2 25 | $26.9M | $93.3M | ||
| Q1 25 | $-5.5M | $31.0M | ||
| Q4 24 | $16.3M | $77.5M | ||
| Q3 24 | $14.5M | $54.7M | ||
| Q2 24 | $15.5M | $57.5M |
| Q1 26 | — | — | ||
| Q4 25 | -1.4% | — | ||
| Q3 25 | -10.6% | — | ||
| Q2 25 | 15.0% | 29.4% | ||
| Q1 25 | -3.5% | 9.8% | ||
| Q4 24 | 12.6% | 26.1% | ||
| Q3 24 | 10.8% | 18.9% | ||
| Q2 24 | 10.7% | 18.8% |
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 0.9% | 1.5% | ||
| Q1 25 | 1.4% | 3.2% | ||
| Q4 24 | 2.1% | 2.3% | ||
| Q3 24 | 1.3% | 3.2% | ||
| Q2 24 | 2.2% | 5.9% |
| Q1 26 | — | — | ||
| Q4 25 | -0.09× | — | ||
| Q3 25 | -1.17× | — | ||
| Q2 25 | 1.88× | — | ||
| Q1 25 | -0.32× | 1.82× | ||
| Q4 24 | 17.56× | 2.42× | ||
| Q3 24 | 3.48× | 1.90× | ||
| Q2 24 | 2.86× | 1.86× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IIIN
| Welded Wire Reinforcement | $108.4M | 68% |
| PC Strand | $51.6M | 32% |
TECH
| Protein Sciences segment revenue | $226.2M | 73% |
| Diagnostics and Spatial Biology segment revenue | $85.6M | 27% |
| Other revenue (1) | $5.4M | 2% |
